In Vitro Study of Interleukin-6 when Used at Low Dose and Ultra-Low Dose in Micro-Immunotherapy

In Vitro Study of Interleukin-6 when Used at Low Dose and Ultra-Low Dose in Micro-Immunotherapy

As one of the major cytokines implicated in the orchestration of immune responses, interleukin 6 (IL-6) can either act as a pro- or an anti-inflammatory factor, depending on the micro-environment. In micro-immunotherapy (MI) medicines, IL-6 is employed at low doses (LD) and ultra-low doses (ULD), ex...

Full description

Bibliographic Details
Main Authors: Camille Jacques, Flora Marchand, Mathias Chatelais, Adrien Brulefert, Mathieu Riffault, Ilaria Floris
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Life
Subjects:
micro-immunotherapy
low doses
ultra-low doses
interleukin-6
immune cells models
immune responses modulation
Online Access:https://www.mdpi.com/2075-1729/14/3/375

Similar Items

Similar Items